StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.48 on Friday. The firm has a market cap of $14.43 million, a P/E ratio […]
More Stories
Trump Signs Orders Ending DEI in University Accreditation, Requiring Foreign Gift Disclosure
By Aaron Gifford President Donald Trump on April 23 announced additional education reform measures that he said will promote transparency...
Norway’s PM Set to Visit White House to Strengthen Ties, Navigate Tariffs
By Travis Gillmore WASHINGTON—Norwegian Prime Minister Jonas Gahr Stoere will meet with U.S. President Donald Trump at the White House...
Townsquare Capital LLC Buys Shares of 11,096 Comstock Resources, Inc. (NYSE:CRK)
Townsquare Capital LLC purchased a new position in shares of Comstock Resources, Inc. (NYSE:CRK – Free Report) in the 4th...
Sterling Capital Management LLC Raises Stock Holdings in Mercury Systems, Inc. (NASDAQ:MRCY)
Sterling Capital Management LLC lifted its stake in Mercury Systems, Inc. (NASDAQ:MRCY – Free Report) by 762.6% during the 4th...
Murphy Oil Co. (NYSE:MUR) Shares Purchased by Cerity Partners LLC
Cerity Partners LLC grew its holdings in shares of Murphy Oil Co. (NYSE:MUR – Free Report) by 18.6% in the...
Legal & General Group Plc Sells 3,034 Shares of AMN Healthcare Services, Inc. (NYSE:AMN)
Legal & General Group Plc trimmed its holdings in AMN Healthcare Services, Inc. (NYSE:AMN – Free Report) by 2.8% in...